Table 3. Linear Regression Analysis for the Association of Clinical and Plaque Characteristics With Plaque Progression.
| Variable | Univariate | Multivariate | ||
|---|---|---|---|---|
| β (SE) | P value | β (SE) | P value | |
| Statin use | 0.139 (0.056) | <.001 | 0.012 (0.046) | .67 |
| Diameter stenosis | 0.302 (0.001) | <.001 | 0.006 (0.133) | .84 |
| Baseline PAV | 0.540 (0.409) | <.001 | 0.445 (0.509) | <.001 |
| Positive remodeling | 0.347 (0.054) | <.001 | 0.105 (0.055) | .001 |
| Low-attenuation plaque | 0.228 (0.065) | <.001 | 0.044 (0.059) | .12 |
| Spotty calcification | 0.209 (0.067) | <.001 | 0.005 (0.061) | .86 |
| ASCVD risk score | 0.259 (0.264) | <.001 | 0.108 (0.238) | <.001 |
Abbreviations: ASCVD, atherosclerotic cardiovascular disease; PAV, percent atheroma volume.